INTRODUCTION
Infection with human immunodefi ciency virus (HIV) is a pandemic issue. [1, 2] With adventure of anti-retroviral treatments (ART), HIV infection is now treated as a chronic disease. [3, 4] HIV infection is o en associated with a variety of changes in blood biochemical and metabolic parameters including changes in serum glucose and lipid profi les, [5] [6] [7] [8] [9] bone metabolism, [10] lactic acidosis, [7] and thrombocytopenia. These changes have been also observed in relation to the antiretroviral regimens. [3, [6] [7] [8] 11, 12] Despite increasing number of studies about metabolic and hematologic alterations in relation to HIV infection and the antiretroviral treatments, there is a paucity of knowledge regarding these alterations in relation to process of HIV infection, its progress to AIDS, and type of antiretroviral regimens which are widely administered.
The present study aimed to investigate metabolic, biochemical, and hematological alterations in relation to HIV infection status, development of AIDS, and type Background: Our study aimed to determine if alteration of metabolic parameters is associated with the severity of human immunodefi ciency virus (HIV) infection, progress to acquired immunodefi ciency syndrome (AIDS), or with the type of antiretroviral treatment (ART).
Materials and Methods:
In a cross-sectional study among 114 HIV infected patients, we measured hematological and biochemical parameters to assess metabolic alterations according to the disease process and anti-retroviral treatment. Results: Of 114 HIV-positive patients, there were 82 AIDS patients receiving ART and 32 HIV patients without treatment. Alkaline phosphatase and parathyroid hormone (PTH) had lower serum levels in HIV patients with CD4 + cell count ≤250 (P < 0.01). CD4 + cell count was higher in patients receiving Protease Inhibitors (PI) and Nucleoside Reverse Transcriptase Inhibitors (NRTI) regimen compared with those treated with Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTI) and NRTI or NRTI alone. Calcium (Ca) serum level was lower in patients with only NRTI regimen while Phosphorus (P) serum level was higher in patients on NNRTI and NRTI (P < 0.05). Conclusion: CD4 + cell count ≤250 cells/μl in HIV-positive patients is associated with decreased level of triglyceride and PTH. Moreover, patients receiving NRTI regimen alone have lower Ca level while this regimen in combination with NNRTI or PI has a positive correlation with P serum level.
(cART). [1] Another classification was also performed according to CD4 + cell counts (CD4 + < 250 cells/ml and CD4 + > 250 cells/ml). A comparison of study parameters was then performed between each of these 2 paired groups of patients. In another set of analysis, patients on antiretroviral treatment were compared with patients who were not under any antiretroviral regimen. We also compared each group of AIDS patients according to their cART regimen ( 
RESULT
A total of 114 HIV-positive patients were enrolled in this study, 80 males and 34 females. HIV-positive patients were classifi ed into two groups according to their disease status, 32 HIV-infected patients and 82 AIDS patients receiving cART. Table 1 presents biochemical and hematological parameters in the study patients. A considerable proportion of patients had signifi cantly high TC serum levels and low HDL-c. Low serum level of Vit D (<50 nmol/L), low serum PTH (<10 pg/ml), and high serum level of P (4.5 mg/ml) were prevalent in this population (92.1%, 11.4%, and 8.8%, respectively). Moreover, 83.8% of patients had CD4 + cell count <500 /μl while CD8 + cell count <375 /μl was found in 10.5% of patients. On the other hand, 91.9% of HIV patient had CD4 + /CD8 + ratio less than 0.9 [ Table 1 ].
Hematological and biochemical parameters

Transmission routes of HIV infection
Sixty HIV-infected patients (52.6%) reported their infection through intravenous drug use (IDU) followed by heterosexual contact (40 patients, 35.1%), blood born transmission (3 patients, 2.6%), and prenatal transmission (1 patient, 0.9%). Transmission route was not determined in 10 patients (8.8%). When the IDU patients were compared with the heterosexual patients, there was no signifi cant diff erence (P > 0.05) for biochemical parameters except for platelet counts (188.15 ± 10.48 /μl in IDU group vs 224.60 ± 12.06 /μl in the heterosexual group).
Correlation between hematological and biochemical parameters According to Table 2 , there is a significant reverse correlation between serum levels of Ca and P (r = −0. 
Comparison of HIV-positive patients based on CD4 + cell count (<250 cells/μl)
We classifi ed all the patients by CD4
+ cell count into two groups based on the AIDS classifi cation (1), one group with CD4 + < 250 cells/μl and another group with CD4 + > 250 cells/μl. Study variables were compared between the two groups. Mean serum levels of triglyceride and PTH were signifi cantly lower in patients with CD4
+ < 250 cells/μl compared with the group of CD4 + > 250 cells/μl (123.22 ± 5.67 mg/dl and 17.37 ± 1.36 pg/ml vs 154.27 ± 13.86 mg/dl, and 22.90 ± 1.75 pg/ml, P = 0.03 and P = 0.02, respectively). No signifi cant diff erence was observed between the two groups in terms of other parameters (P > 0.05). Of patients with CD4 + < 250 cells/μl, two patients (3.3%) and 9 patients (15%) had alkaline phosphatase and triglyceride levels above the normal range, respectively, which was signifi cantly diff erent when compared to 10 patients (19.9%) and 1 patient (2%) in another group with CD4 + > 250 cells/μl (P < 0.05). + Ratio in HIV and AIDS patients were 0.58 ± 0.40 and 0.36 ± 0.27, respectively (P < 0.001). Calcium, alkaline phosphatase, and HDL-c were slightly elevated among AIDS patients while PTH, Vit D, and TG serum levels were slightly reduced. However, none of these alterations revealed a statistically signifi cant diff erence (P > 0.05).
Comparison of AIDS patients under antiretroviral regimen vs non-treated HIV-positive patients
Comparison of metabolic parameters between AIDS patients according to the types of antiretroviral therapies [Table 3]
There was no statistically signifi cant diff erence in terms of serum metabolic and biochemical parameters between AIDS patients under ART including Zidovudine (66 patients; 80.5%), Lamivudine (78 patients; 95.12%), Stavudine (4 patients; 4.9 %), Tenofovire (5 patients; 6.1%), and Didanosine (3 patients; 3.65%) and HIV-positive patients without ART (P > 0.05).
A signifi cantly lower level of CD4 + cell count (234.05 ± 22.65 cells/μl vs 370.12 ± 35.52 cells/μl, P < 0.05) as well as a signifi cantly higher level of phosphorus (3.73 ± 0.12 mg/dl vs 3.21 ± 0.11 mg/dl, P < 0.05) were observed in patients treated with Efavirenz (NNRTI) (63 patients; 76.83%) compared with patients treated with a cART lacking Efavirenz.
Patients treated with PI (Kaletra in this study) (13 patients; 15.85%) were signifi cantly older (45.15 ± 14 years vs 37.04 ± 8.86 years) and had higher levels of CD4 + cell count (380.08 ± 43.45 cells/μl vs 240.39 ± 21.77 cells/μl, P < 0.05) compared to the patients receiving other types of ART.
Our AIDS patients receiving cART were divided in turn into 3 groups, 65 patients (79.26%) were on NNRTI and NRTI regimen, 13 patients (15.85%) were on PI and NRTI regimens, and 4 patients (4.89%) only received NRTI. Table  3 shows the impact of diff erent cART regimens on serum biochemical parameters. Mean age and serum level of Ca were signifi cantly lower in patients receiving only NRTI compared to the patients on PI and NRTI or NNRTI and NRTI regimen (P < 0.05). Moreover, a signifi cantly higher level of phosphorus was found in patients receiving NNRTI and NRTI compared with those patients not receiving this type of regimen (P < 0.05). However, mean levels of ALP and Vit D were not signifi cantly diff erent among these patients.
Mean level of CD4 + cell count were signifi cantly higher in patients on PI and NRTI compared with those on NNRTI and NRTI regimen (P < 0.05). However, despite a higher serum level of TG, HDL-c, and LDL-c in these patients, the diff erence was not statistically signifi cant (P > 0.05).
DISCUSSION
The aim of our study was to evaluate the eff ects of HIV infection, advancement of the disease from early infection to development of AIDS, and antiretroviral therapies on metabolic and biochemical parameters. Our fi ndings revealed that except for calcium, other biomarkers of bone metabolism including P, ALKP, 1,25 Vit D, and PTH were signifi cantly diff erent between AIDS and non-AIDS HIV patients. PTH and 1,25 Vit D were signifi cantly lower among HIV-positive patients while P and ALKP revealed a higher serum levels. Other studies have shown a lower mean level for serum Ca among HIV-positive individuals. [2, 3] Lower PTH and Vit D has been suggested to be an underlying cause. [21] Piso et al. have shown a higher serum level of ALKP in patients receiving antiretroviral treatment [22] and concluded an increased bone turn-over. Osteoporosis and osteopenia have also been associated with HIV infection and more frequently with PIs and ART. [2, 4] In our study, Ca and Vit D were lower among HIV-positive patients while ALKP and PTH showed a higher value. The lower level of Vit D and Ca and PTH are consistent with the literature. Increased ALKP as a marker for bone turn-over may also occur due to increased bone resorption and formation. [21] This has been shown to be correlated with ART rather than HIV infection alone which have been responsible for decreased bone metabolism before introduction of ART.
Lipid metabolism has shown extensive alterations due to HIV infection before ART. This includes decreased serum levels of LDL [5] [6] [7] [8] and HDL [5] [6] [7] [8] [9] along with increased level of TG as a result of increased VLDL. [7, 8, 10, 11] However, the decreased level of LDL was not as frequent as low level of HDL. [8] The most prevalently reported pa ern of lipid profi le alterations includes decreased level of HDL as well as increased LDL, TG, and VLDL. [5] [6] [7] [8] [11] [12] [13] Despite existing evidence, our HIVinfected population had a diff erent pa ern of lipid profi le alterations by which all the parameters were decreased. It is strongly hypothesized that a decreased lipid profi le may stem from a lower socioeconomic status of people in developing countries. IDU as the most common rout of transmission would point to a low social position as well.
Hematologic parameters have been also shown to alter in HIV infection. This may refer to anemia, thrombocytopenia, and leucopenia due to ART [14, 15] or the infection itself. [16, 17] Among our variables, Plt change was consistent with other studies in which thrombocytopenia have been widely reported. [14, 16, 17] Transmission rout only aff ected the Plt count in our study showing lower values among IDU patients. There is a limited number of studies regarding the possible eff ect of IDU in Plt count. [18, 19] Although it may occur due to autoimmunity, intravenous drug injection has been independently contributed to thrombocytopenia.
Hypercholesterolemia, hypertriglyceridemia, and osteoporosis [4, 20, 21] have all been reported to be associated with ART. [22] However, no metabolic changes were signifi cantly related with antiretroviral drugs in our study. As our results suggest, only Ca and P were signifi cantly diff erent between diff erent types of ART. However, no lipid alteration was found in relation to the type of cART. NNRTI and NRTI were also shown to increase P serum level. The adventure of HAART has raised concern regarding metabolic complications in the susceptible HIV patients. Although our study could not prove the eff ect of cART on metabolic and biochemical status, future studies are required to investigate such relationship in larger cohort of patients.
CONCLUSION
CD4
+ cell count ≤250 cells/μl in HIV-positive patients is associated with decreased level of triglyceride and PTH. Moreover, patients receiving NRTI regimen alone have lower Ca level while this regimen in combination with NNRTI or PI has a positive correlation with P serum level. There was no other diff erence in metabolic and biochemical parameters between AIDS patients receiving cART and HIV-positive patients without cART.
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